A Study to Evaluate the Efficacy and Safety of AST-001 in ASD Children

Clinical trial NCT06333964 · COMPLETED

Trial details

NCT number: NCT06333964
Sponsor: Astrogen, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Autism Spectrum Disorder

Start date: 2023-08-29
Primary completion: 2024-12-05
Enrollment: 169

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.